Increasing PrEP With Trans Women in the Deep South

Description

The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence among trans women via a single arm stepped wedge clinical trial. The main question is to compare PrEP uptake and adherence outcomes among trans women in the T'Cher intervention to the delayed study arm.

Conditions

Hiv

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence among trans women via a single arm stepped wedge clinical trial. The main question is to compare PrEP uptake and adherence outcomes among trans women in the T'Cher intervention to the delayed study arm.

T'Cher, Take Charge: Increasing PrEP Awareness, Uptake and Adherence Through Health Care Empowerment and Addressing Social Determinants of Health Among Racially Diverse Trans Women in the Deep South

Increasing PrEP With Trans Women in the Deep South

Condition
Hiv
Intervention / Treatment

-

Contacts and Locations

New Orleans

NO/AIDS Task Force d.b.a. CrescentCare, New Orleans, Louisiana, United States, 70117

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Provision of signed and dated informed consent form
  • * Declaration of willingness to comply with all study procedures and availability during the study
  • * Age 18 years old or older
  • * Male sex designated at birth
  • * Identify as trans woman, woman or another gender identity not associated with being a man
  • * Desire to use or re-start PrEP
  • * HIV uninfected
  • * Speaks English or Spanish
  • * Live in the New Orleans metropolitan statistical area (which includes 8 parishes)
  • * Confirmed HIV infection by rapid algorithm testing and/or laboratory testing (described above)
  • * Prior or current participation in the active arm of an HIV vaccine trial with evidence of vaccine-induced seropositivity
  • * Concurrent or planned enrollment in a research study that provides PrEP
  • * Unwilling to attend quarterly follow-up visits, which will include survey participation
  • * Has any other condition which, based on the opinion of the investigator, would preclude provision of informed consent; make participation in the project unsafe; complicate interpretation of outcome data; or otherwise interfere with achieving the project objectives

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

CrescentCare,

Study Record Dates

2026-07-31